Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Alexandre

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
The Lancet. Haematology|December 21, 2020
Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance databasePierre-Marie Morice, Alexandra Leary, Charles Dolladille, et al.
Experimental Hematology & Oncology|March 5, 2025
Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysisJoachim Alexandre, Jonaz Font, Thibault Lenormand, et al.
Clinical Medicine Insights. Cardiology|January 19, 2018
Rationale and Design for a Monocentric Prospective Study: Sleep Apnea Diagnosis Using a Novel Pacemaker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction (SAPAAD Study)Laure Champ-Rigot, Virginie Ferchaud, Jean-Noël Prévost, et al.
Therapie|September 25, 2017
[Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database]Xavier Humbert, Charles Dolladille, Marion Sassier, et al.
Current Pharmaceutical Design|January 13, 2021
Impact of Sex on Office White Coat effect Tail: A ReviewXavier Humbert, Sophie Fedrizzi, Agnès Hofferer, et al.
Bulletin Du Cancer|January 23, 2026
[Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care]Yann Neuzillet, Constance Thibault, Loïc Mourey, et al.
European Heart Journal|September 16, 2021
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysisCharles Dolladille, Julia Akroun, Pierre-Marie Morice, et al.
Human Vaccines & Immunotherapeutics|November 10, 2022
COVID-19 vaccines associated with vasovagal malaise: A retrospective study in two mass vaccination centers and analysis of the WHO pharmacovigilance databaseBasile Chrétien, Rhéda Stroiazzo, Leila Troussier, et al.
BMJ Open|April 7, 2026
Identification of immunomodulators associated with atrial fibrillation reporting to better understand AF immunologic mechanisms: a Vigibase retrospective disproportionality analysis and a literature reviewJonaz Font, Charles Dolladille, Jordane Divoux, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 5, 2013
Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimizationJoachim Alexandre, Eric Saloux, Alain Lebon, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
The Lancet. Haematology|December 21, 2020
Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance databasePierre-Marie Morice, Alexandra Leary, Charles Dolladille, et al.
Experimental Hematology & Oncology|March 5, 2025
Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysisJoachim Alexandre, Jonaz Font, Thibault Lenormand, et al.
Clinical Medicine Insights. Cardiology|January 19, 2018
Rationale and Design for a Monocentric Prospective Study: Sleep Apnea Diagnosis Using a Novel Pacemaker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction (SAPAAD Study)Laure Champ-Rigot, Virginie Ferchaud, Jean-Noël Prévost, et al.
Therapie|September 25, 2017
[Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database]Xavier Humbert, Charles Dolladille, Marion Sassier, et al.
Current Pharmaceutical Design|January 13, 2021
Impact of Sex on Office White Coat effect Tail: A ReviewXavier Humbert, Sophie Fedrizzi, Agnès Hofferer, et al.
Bulletin Du Cancer|January 23, 2026
[Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care]Yann Neuzillet, Constance Thibault, Loïc Mourey, et al.
European Heart Journal|September 16, 2021
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysisCharles Dolladille, Julia Akroun, Pierre-Marie Morice, et al.
Human Vaccines & Immunotherapeutics|November 10, 2022
COVID-19 vaccines associated with vasovagal malaise: A retrospective study in two mass vaccination centers and analysis of the WHO pharmacovigilance databaseBasile Chrétien, Rhéda Stroiazzo, Leila Troussier, et al.
BMJ Open|April 7, 2026
Identification of immunomodulators associated with atrial fibrillation reporting to better understand AF immunologic mechanisms: a Vigibase retrospective disproportionality analysis and a literature reviewJonaz Font, Charles Dolladille, Jordane Divoux, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 5, 2013
Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimizationJoachim Alexandre, Eric Saloux, Alain Lebon, et al.
Pageof 15